Glipizide / metformin Alternatives Compared
Glipizide / metformin | Mounjaro (tirzepatide) | Semaglutide |
|
---|
Glipizide / metformin | Mounjaro (tirzepatide) | Semaglutide |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Type 2 Diabetes. Glipizide / metformin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Type 2 Diabetes. Mounjaro may also be used for purposes not listed in this medication guide. |
Prescription only
Semaglutide (Ozempic, Rybelsus) lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the... View more |
||||||||||||||||
More about Glipizide / metformin | More about Mounjaro (tirzepatide) | More about Semaglutide | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Glipizide / metformin has an average rating of 3.5 out of 10 from a total of 2 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 50% reported a negative effect. |
Mounjaro has an average rating of 8.5 out of 10 from a total of 1434 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 6% reported a negative effect. |
Semaglutide has an average rating of 6.9 out of 10 from a total of 2750 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Glipizide / metformin side effects |
View all Mounjaro side effects |
View all Semaglutide side effects |
||||||||||||||||
Drug Class | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
Lower cost generic |
N/A |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Glipizide / metformin prices |
View all Mounjaro prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Dosage Forms | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
Other tirzepatide brands include: Zepbound | Ozempic, Rybelsus, Wegovy | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
6.2 hours |
120 hours |
168 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 568 drugs are known to interact with Glipizide / metformin:
|
A total of 416 drugs are known to interact with Mounjaro:
|
A total of 275 drugs are known to interact with Semaglutide:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
||||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
October 21, 2002 |
N/A |
December 05, 2017 |
||||||||||||||||
WADA Class View classifications | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient Resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.